Zalcitabine

In the US, Zalcitabine (zalcitabine systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat HIV Infection.

US matches:

• Zalcitabine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AF03

CAS registry number (Chemical Abstracts Service)

0007481-89-2

Chemical Formula

C9-H13-N3-O3

Molecular Weight

211

Therapeutic Category

Antiviral agent, HIV reverse transcriptase inhibitor

Chemical Name

2', 3'-Dideoxycytidine

Foreign Names

• Zalcitabinum (Latin)
• Zalcitabin (German)
• Zalcitabine (French)
• Zalcitabina (Spanish)

Generic Names

• Zalcitabine (OS: BAN, USAN)
• ddC (IS)
• NSC 606170 (IS)
• Ro 24-2027/000 (IS)
• Zalcitabine (PH: USP 32)

Brand Names

• DDC
  Elvetium, Peru; Ivax, Argentina



• Hivid
  Chugai, Japan; Roche, Bangladesh; Roche, Spain; Roche, Israel; Roche, Oman; Roche, Turkey; Roche, United States; Roche, Uruguay



• Virorich
  Richmond, Argentina; Richmond, Peru



• Zalcitabina
  Richmond, Peru

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.